TITLE

Thyrotropin-secreting pituitary adenomas: diagnosis and management of patients from one Chinese center

AUTHOR(S)
Zhao, Weiwei; Ye, Hongying; Li, Yiming; Zhou, Linuo; Lu, Bin; Zhang, Shuo; Wen, Jie; Li, Shiqi; Yang, Yehong; Hu, Renming
PUB. DATE
October 2012
SOURCE
Wiener Klinische Wochenschrift;Oct2012, Vol. 124 Issue 19/20, p678
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Thyrotropin-secreting pituitary adenoma (TSHoma) is rare and it is also a rare cause of thyrotoxicosis. Failure to detect the presence of TSHoma may result in dramatic consequences. This study is a review of our experience in the management of TSHoma at Huashan Hospital, China. Methods: We followed up eight patients with TSHoma (five males and three females) between 2006 and 2011. The patients' medical records were retrieved, and the demographic data, clinical presentation and management, final outcomes and follow-up were reviewed, and surgery performed. Results: All the eight patients had unsuppressed TSH levels with elevated thyroid hormone levels; and neuroimaging revealed pituitary lesions. Five patients (62.5 %) were previously misdiagnosed as primary hyperthyroidism. They received pituitary adenomectomy, somatostatin analogs, and/or radiotherapy after definitive diagnosis. Serum TSH and thyroid hormone levels of all the patients restored to the normal levels during the follow-up. Conclusions: Adenomectomy is not curative in many TSHoma patients, it should be adjuvantly treated by pharmacological and/or radiotherapy, frequently. A combination of adenomectomy, somatostatin analogs, and radiotherapy is often required for long-term management of the disease.
ACCESSION #
83586130

 

Related Articles

  • Pituitary-Thyroid Dysfunction in a Hashimoto's Encephalopathy Patient. Jingsheng Hu; Jianjun He; Meikui Zhang // Neuroscience & Medicine;Dec2012, Vol. 3 Issue 4, p354 

    The pathogenesis of Hashimoto's encephalopathy has not been clearly elucidated and involvement of autoimmune damage has been proposed. We report a 23-year-old man who was emergently hospitalized for paroxysmal syncope and involuntary tremor with normal physical examination except for low heart...

  • MRI BRAIN FINDINGS IN PATIENTS WITH HIGH SERUM PROLACTIN LEVELS. Gul, Seema; Naeem, Muhammad; Islam Khan, Muhammad Zia ul; Adil, Muhammad; Abbas, Syed Hussain; Khan, Ayasha; Naz, Syeda Maria; Khan, Muhammad Usman // JPMI: Journal of Postgraduate Medical Institute;2013, Vol. 27 Issue 4, p376 

    Objective: The purpose of the study was to find MRI findings in patients with Prolactin levels above 1000mIU/L. Methodology: This Retrospective study was conducted in Radiology Department, Rehman Medical Institute, Peshawar, from December 2009 to October 2012. A total of 86 patients, aged 16-48...

  • Prevalence of thyroid dysfunction among young females in a South Indian population. Velayutham, Kumaravel; Arul Selvan, S. Sivan; Unnikrishnan, A. G. // Indian Journal of Endocrinology & Metabolism;Nov/Dec2015, Vol. 19 Issue 6, p781 

    Background: Thyroid disorders are common in India but scarce data exists on its prevalence in young women. Materials and Methods: This study was conducted in female college students in seven colleges in Madurai District, Tamil Nadu. Thyroid-stimulating hormone (TSH) was used as the screening...

  • Importance of Universal screening for thyroid disorders in first trimester of pregnancy. Dave, Anupama; Maru, Laxmi; Tripathi, Megha // Indian Journal of Endocrinology & Metabolism;Sep/Oct2014, Vol. 18 Issue 5, p735 

    Objective: To determine the importance of screening for Thyriod disorders in the first trimester of pregnancy. Materials and Methods: The Study was conducted on 305 patients which were were randomly selected and screened on OPD basis by TSH levels (cut off level 0.10-2.50 mIU/ml). Results: In...

  • Radioiodine Thyroid Ablation in Graves' Hyperthyroidism: Merits and Pitfalls. Nwatsock, J. F.; Taieb, D.; Tessonnier, L.; Mancini, J.; Dong-A-Zok, F.; Mundler, O. // World Journal of Nuclear Medicine;Jan-Jun2012, Vol. 11 Issue 1, p7 

    Ablative approaches using radioiodine are increasingly proposed for the treatment of Graves' disease (GD) but their ophthalmologic and biological autoimmune responses remain controversial and data concerning clinical and biochemical outcomes are limited. The aim of this study was to evaluate...

  • A case of pregnancy with pituitary macroadenoma and apoplexy. Sangeetha, S.; Sachan, Alok; Suresh, V.; Kumar, P. Satish; Bitla, Aparna R.; Lakshmi, A. Y. // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS388 

    Introduction:Pregnancy is associated with an increase in size of pituitary gland and preexisting adenomas. Occurrence of new tumors is rare during pregnancy. But macroadenomas can present for the first time during pregnancy and rarely undergo apoplexy with hypopituitarism. Case Report: A...

  • Radioactive Body Burden Measurements in 131Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131Iodine Clearance. Ravichandran, Ramamoorthy; Al Saadi, Amal; Al Balushi, Naima // World Journal of Nuclear Medicine;Jan2014, Vol. 13 Issue 1, p56 

    Protocols in the management of differentiated thyroid cancer, recommend adequate thyroid stimulating hormone (TSH) stimulation for radioactive 131I administrations, both for imaging and subsequent ablations. Commonly followed method is to achieve this by endogenous TSH stimulation by withdrawal...

  • ACTH-secreting macroadenoma: Experience from a single tertiary care center in India. Kakade, Harshal // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS394 

    Objective: To study clinical profile and treatment outcome of patient of Cushing disease with macroadenoma to a single tertiary care center in India. Patients and Methods: Medical records of 42 patients diagnosed with Cushing macroadenoma from 1993 to 2012 were reviewed. Results: Out of 42...

  • Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly? Bozok Cetintas, Vildan; Zengi, Ayhan; Tetik, Asli; Karadeniz, Muammer; Ergonen, Faruk; Kucukaslan, Ali; Tamsel, Sadik; Kosova, Buket; Sahin, Serap; Saygılı, Fusun; Eroglu, Zuhal // Endocrine (1355008X);Jun2012, Vol. 41 Issue 3, p465 

    Acromegaly is a syndrome that results when the pituitary gland produces excess growth hormone after epiphyseal closure at puberty. Usually, subjects with acromegaly exhibit a 2- to 3-fold higher mortality rate from diseases that are associated with cardiovascular complications when compared to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics